Free Trial

INSPECS Group (SPEC) Competitors

INSPECS Group logo
GBX 43.75 -0.75 (-1.69%)
As of 04:59 AM Eastern

SPEC vs. BVC, AKR, CNSL, ODX, CTEC, AMS, TSTL, ANCR, BVXP, and 4BB

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Tristel (TSTL), Animalcare Group (ANCR), Bioventix (BVXP), and 4basebio (4BB). These companies are all part of the "medical" sector.

INSPECS Group vs.

INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 6.0%. INSPECS Group pays out -24.8% of its earnings in the form of a dividend. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

67.8% of INSPECS Group shares are held by institutional investors. Comparatively, 42.4% of BATM Advanced Communications shares are held by institutional investors. 25.6% of INSPECS Group shares are held by company insiders. Comparatively, 26.2% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.10% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes
BATM Advanced CommunicationsOutperform Votes
190
49.10%
Underperform Votes
197
50.90%

In the previous week, BATM Advanced Communications had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. BATM Advanced Communications' average media sentiment score of 1.32 beat INSPECS Group's score of -0.21 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Overall Sentiment
INSPECS Group Neutral
BATM Advanced Communications Positive

BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than INSPECS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£195.14M0.23-£4.11M-£4.04-10.83
BATM Advanced Communications£130.32M0.68-£278.26K-£0.04-389.65

INSPECS Group has a beta of 2.22, indicating that its share price is 122% more volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500.

BATM Advanced Communications has a net margin of -0.21% compared to INSPECS Group's net margin of -2.10%. BATM Advanced Communications' return on equity of -0.22% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.10% -4.00% 0.45%
BATM Advanced Communications -0.21%-0.22%0.58%

Summary

BATM Advanced Communications beats INSPECS Group on 12 of the 17 factors compared between the two stocks.

Get INSPECS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£44.48M£3.92B£5.33B£2.63B
Dividend Yield2.00%1.99%5.21%5.05%
P/E Ratio-10.8319.1826.77134.99
Price / Sales0.23576.22393.27224,419.26
Price / Cash1.63146.5438.2528.03
Price / Book0.443.136.773.80
Net Income-£4.11M£99.80M£3.23B£5.88B
7 Day Performance-2.34%-0.45%0.43%0.38%
1 Month Performance8.32%10.75%9.07%21.44%
1 Year Performance-36.32%123.44%18.57%129.76%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
N/AGBX 43.75
-1.7%
N/A-39.4%£44.48M£195.14M-10.831,673Gap Down
BVC
BATM Advanced Communications
N/AGBX 15.75
-5.5%
N/A-15.4%£83.64M£130.32M-365.64980Positive News
Gap Down
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.52
-1.2%
N/A-33.0%£6.00M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
1.2996 of 5 stars
GBX 275.40
+0.1%
GBX 301.67
+9.5%
+10.0%£7.00B£2.71B46.3810,000News Coverage
AMS
Advanced Medical Solutions Group
1.972 of 5 stars
GBX 196.96
+0.2%
GBX 300
+52.3%
-7.2%£425.29M£132.18M38.1710
TSTL
Tristel
N/AGBX 388.90
+1.0%
N/A-11.8%£185.78M£42.24M28.46208
ANCR
Animalcare Group
N/AGBX 254.20
-0.7%
N/A+5.5%£174.28M£84.90M4.74220
BVXP
Bioventix
N/AGBX 2,850
-3.4%
N/A-33.7%£149.24M£13.65M18.4312News Coverage
4BB
4basebio
N/AGBX 1,145
+1.8%
GBX 1,600
+39.7%
-20.7%£146.67M£311,000.00-1,467.95101News Coverage

Related Companies and Tools


This page (LON:SPEC) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners